Clinical trial
Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With…
NCT00058084 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00058084 |
|---|---|
| Title | Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer |
| Official title | A Randomized Phase II Study Of BMS 247550 Or Mitoxantrone And Prednisone In Patients With Taxane Resistant Hormone Refractory Prostate Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer |
| Intervention type | Drug |
| Interventions | ixabepilone, mitoxantrone hydrochloride, prednisone |
| Enrollment | 80 |
| Start date | Mar 1, 2003 |
| Primary completion | Oct 1, 2007 |
| First posted | Apr 9, 2003 |
| Last update posted | Feb 23, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: